US‐guided percutaneous needle biopsy of the spleen using 18‐gauge versus 21‐gauge needles

Liang, Ping; Gao, Yang; Wang, Yang; Yu, Xiaoling; Yu, Dejiang; Dong, Baowei

doi:10.1002/jcu.20390

Cited by 45 publications

(40 citation statements)

References 20 publications

(33 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Of these, 25 were excluded from the complication rate arm of the study, while 30 were excluded from the diagnostic accuracy arm of the study for reasons specifi ed in Figure 1 . Nine studies were included in the complication rate arm of the study ( 5,(14)(15)(16)29,(32)(33)(34)(35), and four studies were included in the diagnostic accuracy arm of the study ( 5,6,16,29 ). Personal communication with the author confi rmed that one study contained a subset of patients from another article ( 5,36 ) (Luigi Cavanna, MD, personal communication, July 2010).…”

Section: Resultsmentioning

confidence: 99%

“…Complication rate for total biopsies (FNAB and CNB), FNAB, and CNB was calculated and displayed per study by using a forest plot. Sensitivity analysis was performed by removing cases with needles larger than 18 gauge; this was done because needles larger than 18 gauge are not routinely used in current practice in the spleen, as well as other intraabdominal organs, because of concerns regarding higher rates of hemorrhage ( 5,13,29 ). Pooled summary complication rate for FNAB, CNB, and total biopsies was calculated by using the random-effects model weighted by the inverse variance ( 28 ).…”

Section: Discussionmentioning

confidence: 99%

“…One study incorporated the index test as part of the reference standard for six of the 138 cases; these cases were excluded from the analysis ( 6 ). One study, a randomized control trial, did not specify if there were any withdrawals or refusals to participate ( 29 ). One study did not have a sufficient description of the reference standard in that it did not specify exactly which reference standard was applied to each case ( 16 ).…”

Section: Evidence-based Practice: Complication Rate and Diagnostic Acmentioning

confidence: 99%

See 2 more Smart Citations

Percutaneous Image-guided Biopsy of the Spleen: Systematic Review and Meta-Analysis of the Complication Rate and Diagnostic Accuracy

McInnes

Kielar²,

Macdonald³

2011

Radiology

111

View full text Add to dashboard Cite

Purpose:To use meta-analysis to determine the complication rate and diagnostic accuracy of image-guided percutaneous needle biopsy of the spleen. Materials and Methods:Several electronic databases were searched through July 2010 without language restrictions. Two reviewers independently selected studies that met the inclusion criteria for the diagnostic accuracy and complication rate arms of the study. Study data were independently extracted by the two reviewers. The primary 2 3 2 data were investigated with a random-effects meta-analysis of sensitivity and specifi city. The complication rate data were investigated with a random-effects meta-analysis; sensitivity analysis of complication rate, excluding needles larger than 18 gauge, was performed. Results:Four studies met the inclusion criteria for the diagnostic accuracy arm (639 patients), and nine met the inclusion criteria for the complication rate arm (741 patients). The meta-analysis showed a pooled sensitivity of 87.0% (95% confi dence interval [CI]: 80.7%, 91.4%) and specifi city of 96.4% (95% CI: 81.4%, 99.4%). The pooled major complication rate was 2.2% (95% CI: 0.8%, 5.6%). Sensitivity analysis with the removal of biopsies performed with needles larger than 18 gauge showed a major complication rate of 1.3% (95% CI: 0.6%, 2.5%). The most commonly encountered complications were hemorrhage followed by pain. Conclusion:Image-guided percutaneous biopsy of the spleen demonstrates high diagnostic accuracy and a major complication rate, for needles 18 gauge or smaller, that is similar to that reported for the liver and kidney. This technique should be considered a favorable alternative to splenectomy.q RSNA, 2011

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Evidence-based Practice: Complication Rate and Diagnostic Acmentioning

confidence: 99%

See 1 more Smart Citation

Percutaneous Image-guided Biopsy of the Spleen: Systematic Review and Meta-Analysis of the Complication Rate and Diagnostic Accuracy

McInnes

Kielar²,

Macdonald³

2011

Radiology

111

View full text Add to dashboard Cite

show abstract

“…The sensitivity of core needle biopsy in making a diagnosis is 88% or better in multiple series in the literature (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12). In a study by Muraca et al (4), the biopsy yield in pediatric patients with a focal splenic lesion was 83% with 18-21-gauge needles.…”

Section: Biopsymentioning

confidence: 99%

Image-guided Percutaneous Splenic Interventions

Singh

Shankar²,

Gervais

et al. 2012

RadioGraphics

View full text Add to dashboard Cite

In the spleen, image-guided interventional procedures such as biopsy and catheter drainage have not been widely performed because of the perceived increased risk of complications. The ability of image-guided biopsy to allow tissue diagnosis of a focal splenic mass without the need for splenectomy is the driving force behind use of this procedure in oncology patients. The literature on image-guided splenic biopsy suggests that the highest biopsy yield is achieved with core biopsy and the lowest complication rate is achieved with fine-needle aspiration. Image-guided catheter drainage is an effective alternative to splenectomy for management of infected splenic collections. In clinical practice, image-guided splenic biopsy, fluid aspiration, and catheter drainage have high success rates. Image-guided alcohol ablation is effective in treatment of splenic cysts. The literature on splenic radiofrequency ablation (RFA) is sparse; therefore, further studies are needed to determine the role of RFA in management of splenic neoplasms and hypersplenism. Image-guided percutaneous thrombin injection can be used to treat splenic artery pseudoaneurysms. Awareness of the correct interventional techniques and their limitations is important for safe performance of image-guided percutaneous splenic interventions.

show abstract

“…In the medical literature, fine needle biopsy performed under ultrasound (US) guidance is considered to be the method of choice in obtaining histopathological diagnosis in splenic tumor [16][17][18][19][20].…”

Section: Introductionmentioning

confidence: 99%

Multi-Year Observation of Lung Cancer Metastases to the Spleen

M¹,

Majcher²,

Urbanowicz³

et al. 2013

JMSE-B

View full text Add to dashboard Cite

Abstract:The purpose of our study was to show if there is any correlation between the location of the primary cancer site in the lungs, and the appearance of metastases in the spleen. 1,998 patients with confirmed lung cancer were analyzed. In 22 out of 22 cases, splenic lesions were detected by both, computer tomography (CT) and ultrasound (US) in all 22 of them. All patients with splenic lesions detected by the US underwent US-guided biopsy. Among these patients, metastases to the spleen were histopathologically confirmed in all 22 cases. 18 metastases in the spleen originated from left lung tumors, 3 from right lung tumor. In the 1 case remaining, a pattern of benign lesion was confirmed. The authors came to the conclusion that lung cancer metastases detected in the spleen originate mainly from the left lung cancer which can be caused by higher blood flow to the left lung as compared to the right lung.

show abstract

US‐guided percutaneous needle biopsy of the spleen using 18‐gauge versus 21‐gauge needles

Cited by 45 publications

References 20 publications

Percutaneous Image-guided Biopsy of the Spleen: Systematic Review and Meta-Analysis of the Complication Rate and Diagnostic Accuracy

Percutaneous Image-guided Biopsy of the Spleen: Systematic Review and Meta-Analysis of the Complication Rate and Diagnostic Accuracy

Image-guided Percutaneous Splenic Interventions

Multi-Year Observation of Lung Cancer Metastases to the Spleen

Contact Info

Product

Resources

About